Irvine, CA January 27, 2010 OrthAlign, Inc., a privately held medical device company in Irvine, CA, concluded its Series A financing round with a $5.2 million Series A2 tranche led by California Technology Ventures. Additional participants included Research Corporation Technologies and Okapi Venture Capital. “This round of financing provides us with the capital to launch our first product, the KneeAlign™ system, in 2010, and to continue developing other products in our pipeline,” said Pieter Wolters, OrthAlign’s President and CEO.
About OrthAlign, Inc.:
OrthAlign has developed disposable palmsized, computerassisted surgical devices for use in total jointreplacement. The company received regulatory clearance for clinical use of its first generation KneeAlign product in the United States in September 2009.
About California Technology Ventures, LLC.:
California Technology Ventures in Pasadena, CA, is a venture capital fund that makes direct investments in technology and life science companies. CTV has built a strong reputation for its entrepreneurial approach to investing and working with companies. For more information, visit www.ctventures.com.
About Research Corporation Technologies, Inc.:
Research Corporation Technologies in Tucson, AZ., is a technology investment and management company that provides early stage funding and development for promising biomedical companies and technologies. RCT focuses on technology investments with origins from universities and research institutions worldwide. For more information, visit www.rctech.com.
About Okapi Venture Capital, LLC:
Founded in 2006, Okapi Venture Capital is a seed and early stage venture capital fund headquartered in Laguna Beach, CA. Okapi, with approximately $30 million dollars under management in its current fund, Okapi Ventures I, is focused on seed and early stage life sciences and information technology opportunities in Southern California. For more information, visit www.okapivc.com.
For more information, visit www.orthalign.com.